; and (2) by adding at the end the following new paragraph: (11) Contract Pharmacies The requirements and prohibitions under subsection (a)(1) shall apply, in the case of a covered entity that elects to contract with one or more pharmacies to dispense covered outpatient drugs purchased by a covered entity at or below the applicable ceiling price described in paragraph (1), to patients of the covered entity. . (b) Manufacturer compliance Section 340B(d) of the Public Health Service Act ( 42 U.S.C. 256b ) is amended— (1) in paragraph (1)(B)(vi), by inserting in the case of an overcharge after penalties ; (2) in paragraph (1)(B), by adding at the end the following: (vii) The imposition of sanctions in the form of civil monetary penalties in the case of a violation of subsection (a)(1) or subsection (a)(11), other than an overcharge, which— (I) shall be assessed according to standards established in regulations to be promulgated by the Secretary not later than 180 days after the date of enactment; (II) shall apply to any manufacturer with an agreement under this section that knowingly and intentionally violates a requirement under subsection (a)(1) or subsection (a)(11), other than an overcharge; (III) shall not exceed $2,000,000 for each day of such violation; (IV) shall be determined by the Secretary, taking into account factors such as the nature and extent of the violation and harm resulting from such violation, including, where applicable, the number of drugs affected and the number of covered entities affected; and (V) shall continue to be imposed each day until such manufacturer is no longer in violation of a requirement under subsection (a)(1) or subsection (a)(11), other than an overcharge.